NCT01501448View on ClinicalTrials.gov

Oral Estradiol Valerate Versus Oral Contraceptive Pill in Invitro Fertilization Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

February 28, 2013

Conditions
Infertility
Interventions
DRUG

Levonorgestrel and ethinylestradiol

30 microgram of ethinylestradiol plus levonorgestrel daily for 12 to 16 days

DRUG

Estradiol valerate

4mg estradiol valerate from cycle day 20 till the day before the initiation of the cycle

Trial Locations (1)

28223

IVI Madrid, Madrid

All Listed Sponsors
lead

IVI Madrid

OTHER

NCT01501448 - Oral Estradiol Valerate Versus Oral Contraceptive Pill in Invitro Fertilization Patients | Biotech Hunter | Biotech Hunter